Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

The pharmaceutical CDMO industry

Our latest CDMO report : The majority of pharmaceutical contract manufacturers are privately owned – but for how long?

  • Login to see the comments

  • Be the first to like this

The pharmaceutical CDMO industry

  1. 1. The majority of pharmaceutical contract manufacturers are privately owned – but for how long? EY CDMO Study The large majority of companies in today’s fragmented contract manufacturing landscape are either privately owned, often small family-run or mid-market companies, or assets of private equity funds. These private companies or their assets represented the vast majority of targets for acquisitions in the CDMO space, with a total of 226 (56% of all CDMO deals from 2012 to 2016). 86 80 108 5 115Private strategic Asset of investment firm Asset of public strategic Asset of private strategic Public strategic Number of dealsTarget ownership Private strategic Asset of investment firm Asset of public strategic Asset of private strategic Public strategic 8.2 3.6 6.6 6.3 25.7 EV (US$b)Target ownership

×